Publication | Closed Access

Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism

ThrombosisPhysiologyPharmacologyParathyroid HormoneFibrinolysisVascular BiologyParathyroid GlandOsteoporosisThyroid HormoneMedicineAtherosclerosisThrombin-activatable Fibrinolysis Inhibitor